New developments in diabetes treatments
Over 400 million people have diabetes worldwide.
Amrita Banerjee, assistant professor of pharmaceutical sciences at NDSU, began working with a team last year to develop an insulin pill to change the lives of people living with this disease.
This has been quite a challenge as the body naturally has barriers preventing a pill to work.
The team uses ionic fluid and other FDA approved ingredients to safely and effectively overcome these obstacles.
"We have engineered this insulin pill in such a way that it addresses all the barriers or overcomes all the barriers of absorption," Banerjee said.
The pill is now undergoing rigorous testing and has made significant progress after being tested on rats.
If brought to the public, this pill could replace insulin injections.
"Instead of poking oneself on a daily basis or two times a day, if you can just swallow a pill, that will makes their lives much better," Banerjee said.
She says the pill could increase the possibility of people with diabetes sticking to their insulin routine.
Testing of this insulin pill is continuing at Harvard by Banerjee’s colleagues.
She says that if testing continues to progress positively that this pill could be on the market in 10 to 15 years.